Organon & Co.
OGN· NYSE
Filed Jun 21, 2021 · 10-Q · 82 days after period end · 0001821825-21-000005
| Metric | Q1 2021 | Q1 2020 |
|---|---|---|
| Revenue | $1.51B | $1.78B |
| Net Income | $399.00M | $703.00M |
| EPS Diluted | $1.58 | $2.78 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Organon & Co. · CIK 1821825 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed Jun 21, 2021 · 82 d after period end